compar
nonfat
myocardi
infarct
nonfat
stroke
caus
greater
loss
disabilityadjust
lifeyear
nonetheless
past
decad
clear
impress
declin
incid
stroke
sever
western
nation
posit
chang
occurr
stroke
countri
attribut
primarili
better
screen
treatment
establish
risk
factor
stroke
particularli
hypertens
burden
stroke
greater
asian
countri
western
world
includ
substanti
higher
incid
stroke
myocardi
infarct
howev
data
extent
sever
asia
countri
recent
fare
regard
improv
stroke
outcom
rel
spars
one
studi
suggest
incid
stroke
decreas
japan
overview
studi
reveal
recurr
stroke
decreas
decad
certainli
nationwid
data
evolv
natur
trajectori
stroke
asia
need
research
plan
purpos
object
studi
explor
risk
factor
medic
use
incid
oneyear
recurr
stroke
use
entir
popul
taiwan
nation
health
insur
research
databas
nhird
retrospect
assess
data
collect
taiwan
nhird
taiwan
implement
singlepay
compulsori
nation
health
insur
program
includ
reimburs
outpati
visit
hospit
admiss
prescript
taiwanes
popul
contract
institut
must
file
claim
accord
standard
format
subsequ
transform
nhird
identifi
hospit
patient
year
admit
primari
diagnosi
ischem
stroke
intern
classif
diseas
ninth
revis
code
first
time
prior
studi
valid
diagnosi
acut
ischem
stroke
nation
health
insur
claim
data
use
taiwan
stroke
registri
refer
reveal
posit
predict
valu
sensit
anoth
crosssect
studi
show
among
confirm
case
acut
ischem
stroke
hospit
medic
record
assign
ischem
stroke
princip
diagnosi
nhird
enrol
patient
receiv
brain
comput
tomographi
ct
magnet
reson
imag
mri
hospit
assumpt
patient
symptom
acut
stroke
receiv
brain
imag
approach
intend
exclud
stroke
patient
hospit
rehabilit
chronic
stage
although
brain
imag
especi
ct
may
abl
reveal
cerebr
infarct
patient
symptom
sign
acut
stroke
easili
exclud
intracrani
hemorrhag
thu
nhird
low
probabl
misclassifi
hemorrhag
stroke
ischem
stroke
brain
imag
done
firstev
ischem
stroke
studi
period
defin
index
stroke
patient
exclud
histori
stroke
patient
classifi
three
group
accord
year
stroke
occurr
nationwid
studi
includ
avail
elig
patient
primari
outcom
studi
incid
ischem
stroke
taiwan
incid
rate
defin
number
firstev
stroke
patient
year
divid
midyear
popul
per
popul
lead
secondari
outcom
oneyear
stroke
recurr
rate
defin
number
patient
first
recurr
stroke
ischem
hemorrhag
within
one
year
index
stroke
divid
number
index
stroke
patient
followedup
start
index
stroke
stroke
recurr
one
year
index
stroke
whichev
came
first
baselin
characterist
present
median
interquartil
rang
continu
variabl
percentag
categor
variabl
appropri
statist
analys
perform
sa
statist
softwar
version
sa
institut
inc
cari
usa
total
firstev
ischem
stroke
patient
enrol
averag
age
year
approxim
men
averag
length
hospit
stay
day
half
patient
histori
hypertens
frequenc
hypertens
ischem
stroke
much
differ
three
time
period
frequenc
diabet
mellitu
hyperlipidemia
increas
steadili
studi
period
frequenc
atrial
fibril
chronic
kidney
diseas
heart
failur
also
increas
studi
period
frequenc
brain
ct
use
decreas
brain
mri
use
increas
gener
characterist
describ
tabl
studi
period
mortal
firstev
ischem
stroke
patient
receiv
calcium
channel
blocker
antihypertens
therapi
admiss
throughout
studi
period
use
angiotensin
receptor
blocker
increas
studi
period
frequenc
angiotensinconvertingenzym
inhibitor
diuret
much
among
three
time
section
use
statin
ischem
stroke
patient
increas
stroke
patient
receiv
antiplatelet
respect
respect
ischem
stroke
patient
atrial
fibril
receiv
oral
anticoagul
agent
hospit
incid
rate
ischem
stroke
peopl
age
year
older
decreas
gradual
per
person
per
person
except
obviou
drop
increas
figur
oneyear
stroke
recurr
rate
decreas
gradual
decreas
except
obviou
drop
increas
figur
compar
women
men
higher
incid
rate
recurr
rate
stroke
suspect
sever
acut
respiratori
syndrom
march
juli
taiwan
may
caus
decreas
rate
ischem
stroke
hospit
explor
possibl
explan
drop
stroke
incid
compar
stroke
incid
march
juli
found
stroke
incid
substanti
decreas
may
june
compar
may
june
tabl
studi
provid
overview
baselin
characterist
risk
factor
medic
use
hospit
incid
oneyear
recurr
firstev
ischem
stroke
use
entir
popul
taiwan
sever
find
strength
limit
merit
discuss
use
stroke
hospit
repres
incid
recurr
ischem
stroke
assumpt
acut
ischem
stroke
patient
hospit
current
health
care
system
taiwan
support
encourag
practic
howev
small
proport
patient
like
minor
stroke
may
receiv
brain
imag
emerg
depart
outpati
clinic
hospit
due
variou
reason
nonavail
bed
patient
want
wait
found
incid
recurr
stroke
drop
may
june
fierc
sar
epidem
taiwan
period
time
patient
medic
doctor
less
inclin
facilit
hospit
unless
patient
condit
highli
sever
thu
mani
patient
stroke
rel
minor
sever
may
count
analysi
therebi
potenti
underestim
real
incid
recurr
ischem
stroke
period
time
two
studi
explor
incid
stroke
conduct
respect
certain
commun
taiwan
annual
incid
rate
stroke
peopl
age
year
older
studi
per
popul
populationbas
stroke
survey
report
annual
incid
rate
stroke
peopl
age
year
older
per
popul
sinc
current
popul
age
older
focus
incid
ischem
stroke
well
incid
stroke
like
declin
annual
incid
rate
lower
studi
characterist
stroke
risk
factor
studi
gener
consist
larg
stroke
registri
rate
statin
vs
antiplatelet
vs
use
hospit
somewhat
lower
studi
current
studi
includ
firstev
ischem
stroke
prior
studi
also
includ
recurr
ischem
stroke
patient
may
led
treat
medic
doctor
adopt
aggress
vascular
risk
reduct
strategi
also
hospit
particip
stroke
registri
presum
highli
motiv
improv
care
qualiti
may
gener
awar
ofinterest
use
evidencebas
therapi
stroke
risk
reduct
found
mortal
rate
lower
studi
compar
prior
stroke
registri
studi
vs
like
due
fact
studi
enrol
firstev
ischem
stroke
inform
compar
trend
stroke
incid
recurr
manag
stroke
taiwan
data
asian
countri
korea
among
hospit
admiss
stroke
primari
diagnost
code
hospit
ischem
stroke
increas
substanti
korea
appar
rise
annual
ischem
stroke
incid
korea
like
due
increas
countri
elderli
popul
howev
median
age
current
studi
taiwan
chang
studi
period
moreov
comparison
survey
data
obtain
vs
show
signific
improv
hypertens
awar
treatment
control
taiwan
may
contribut
declin
incid
ischem
stroke
ischem
stroke
incid
popul
age
year
per
personyear
includ
firstev
recurr
ischem
stroke
korea
per
person
popul
age
year
older
firstev
ischem
stroke
annual
rate
recurr
ischem
stroke
japan
vs
annual
recurr
stroke
ischem
hemorrhag
rate
note
taiwan
fukuoka
ischem
stroke
registri
mean
age
year
hypertens
diabet
mellitu
hyperlipidemia
atrial
fibril
studi
similar
frequenc
stroke
risk
factor
except
patient
atrial
fibril
studi
sinc
diagnosi
atrial
fibril
hospit
ischem
stroke
patient
typic
reli
singl
baselin
electrocardiogram
histori
atrial
fibril
conceiv
frequenc
paroxysm
atrial
fibril
admit
ischem
stroke
patient
taiwan
might
underestim
among
ischem
stroke
patient
atrial
fibril
studi
vs
chines
ischem
stroke
registri
receiv
oral
anticoagul
hospit
underus
oral
anticoagul
therapi
elig
asian
stroke
patient
hospit
may
part
due
concern
hemorrhag
transform
also
patient
receiv
statin
therapi
studi
discharg
vs
fukuoka
stroke
registri
highli
compar
compar
prior
studi
base
control
arm
clinic
trial
secondari
stroke
prevent
current
studi
higher
recurr
rate
stroke
vs
differ
may
exist
prior
studi
exclud
patient
atrial
fibril
sever
carotid
stenosi
studi
includ
firstev
ischem
stroke
patient
also
peopl
particip
clinic
trial
may
receiv
rigor
risk
factor
control
turn
lower
recurr
stroke
furthermor
current
studi
enrol
patient
acut
stage
risk
recurr
stroke
high
wherea
secondari
stroke
prevent
trial
gener
enrol
patient
acut
stage
found
oneyear
recurr
stroke
declin
may
explain
increas
use
statin
antiplatelet
agent
oral
anticoagul
agent
atrial
fibril
hospit
among
period
time
addit
limit
mention
nhird
provid
inform
establish
stroke
risk
factor
eg
smoke
blood
pressur
level
followup
period
also
explor
medic
use
outpati
clinic
discharg
firstev
ischem
stroke
thu
could
explor
impact
factor
incid
recurr
stroke
conclus
accord
recent
trend
around
world
observ
annual
incid
oneyear
recurr
rate
stroke
declin
last
decad
taiwan
howev
would
seem
magnitud
reduct
incid
stroke
seen
western
nation
approxim
much
greater
modest
decreas
note
taiwan
observ
rise
use
statin
antiplatelet
agent
oral
anticoagul
agent
atrial
fibril
taiwan
period
time
probabl
contribut
declin
rate
stroke
appear
room
improv
risk
factor
control
taiwan
hope
gain
least
level
decreas
incid
stroke
observ
western
countri
